Influence on the bone mineral density and bone metabolism marker after the interruption and reinitiation of monthly MINODRONATE (cas 127657-42-5) therapy in postmenopausal women with osteoporosis
-
Add time:08/08/2019 Source:sciencedirect.com
ObjectivesThe purpose of this study was to investigate the influences of interruption and reinitiation of monthly MINODRONATE (cas 127657-42-5) therapy on the bone mineral density (BMD) and bone metabolism markers in postmenopausal women with osteoporosis.
We also recommend Trading Suppliers and Manufacturers of MINODRONATE (cas 127657-42-5). Pls Click Website Link as below: cas 127657-42-5 suppliers
Prev:Solvolysen des 1 : 2-benzocyclooctenyl-(3)-methyltosylats
Next:Initiation of Monthly MINODRONATE (cas 127657-42-5) Therapy at an Early Stage After Hip Fracture) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- MINODRONATE (cas 127657-42-5), a Newly Developed Nitrogen-Containing Bisphosphonate, Suppresses Melanoma Growth and Improves Survival in Nude Mice by Blocking Vascular Endothelial Growth Factor Signaling08/17/2019
- MINODRONATE (cas 127657-42-5), a nitrogen-containing bisphosphonate, is a promising remedy for treating patients with diabetic retinopathy08/16/2019
- A double-blinded head-to-head trial of MINODRONATE (cas 127657-42-5) and alendronate in women with postmenopausal osteoporosis08/15/2019
- Comparison of effectiveness and safety of ibandronate and MINODRONATE (cas 127657-42-5) combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study08/14/2019
- Effects of MINODRONATE (cas 127657-42-5) on cortical bone response to mechanical loading in rats08/13/2019
- Combined treatment with MINODRONATE (cas 127657-42-5) and vitamin C increases bone mineral density and strength in vitamin C-deficient rats08/12/2019
- Effect of MINODRONATE (cas 127657-42-5) on the speed of sound of the calcaneus in postmenopausal women with an increased risk of fractures: A clinical practice-based observational study08/11/2019
- Monthly MINODRONATE (cas 127657-42-5) inhibits bone resorption to a greater extent than does monthly risedronate08/10/2019
- Initiation of Monthly MINODRONATE (cas 127657-42-5) Therapy at an Early Stage After Hip Fracture08/09/2019
